PCAT6 may be a new prognostic biomarker in various cancers: a meta-analysis and bioinformatics analysis

BACKGROUND: LncRNA prostate cancer-associated transcript 6 (PCAT6) has been reported to be dysregulated in several cancers and is associated with tumor progression. Here, we have performed a meta-analysis to assess the general prognostic role of PCAT6 in malignancies. METHODS: Four public databases...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Song-bo, Cheng, Qing-hao, Gong, Shi-yi, Lu, Ting-ting, Guo, Shi-fang, Song, Shao-ming, Yang, Yu-ping, Cui, Qi, Yang, Ke-hu, Qian, Yao-wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273986/
https://www.ncbi.nlm.nih.gov/pubmed/34247605
http://dx.doi.org/10.1186/s12935-021-02079-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273986/
https://www.ncbi.nlm.nih.gov/pubmed/34247605
http://dx.doi.org/10.1186/s12935-021-02079-4

Ejemplares similares